Discover 1,670 paid clinical trials in Princeton, New Jersey. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,670
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
for
Non-small Cell Lung Cancer (NSCLC)
Location: East Brunswick NJ, The Bronx NY, Washington D.C. DC,
Sponsor: Genmab
Sex: All
Age: 18+
Code: NCT07288177
Phase 2, Recruiting
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumor
Location: East Brunswick NJ, New Brunswick NJ, Lake Success NY,
Sponsor: Pliant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06270706
Phase 1, Recruiting
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
for
Non-small Cell Lung Cancer
Location: East Brunswick NJ, Florham Park NJ, Paramus NJ,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712316
Phase 2, Phase 3, Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
for
Colorectal Neoplasms
Location: East Brunswick NJ, New Brunswick NJ, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06662786
Phase 3, Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: East Brunswick NJ, Providence RI, Toronto, Milwaukee WI,
Sponsor: Daiichi Sankyo
Sex: All
Age: 18+
Code: NCT05875168
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Lilac Device Trial - IMPACT: A Clinical Investigation on IMproving Peripheral Neuropathy Induced by Chemotherapy With Advanced Compression Technology - A Safety and Efficacy Study
for
Chemotherapy Induced Peripheral Neuropathy (CIPN)
Location: East Brunswick NJ, Mullica Hill NJ, Vineland NJ,
Sponsor: Luminate Medical, Inc.
Sex: All
Age: 18+
Code: NCT07142304
Recruiting
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
for
Non Small Cell Lung Carcinoma, c-MET
Location: East Brunswick NJ, Easton PA, Shirley NY, Leesburg VA,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06772623
Phase 1, Phase 2, Recruiting
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
for
Neoplasms
Location: East Brunswick NJ, New Brunswick NJ, Philadelphia PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06150157
Phase 1, Recruiting
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
for
Prostatic Neoplasms
Location: East Brunswick NJ, Philadelphia PA, New York NY,
Sponsor: Janssen Research & Development, LLC
Sex: Male
Age: 18+
Code: NCT06095089
Phase 1, Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Location: East Brunswick NJ, Philadelphia PA, York PA,
Sponsor: Guardant Health, Inc.
Sex: All
Age: 18+
Code: NCT05059444
Recruiting
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
for
Non-Small Cell Lung Cancer, c-MET
Location: East Brunswick NJ, Teaneck NJ, The Bronx NY,
Sponsor: AbbVie
Sex: All
Age: 18+
Code: NCT06568939
Phase 2, Recruiting
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
for
Multiple Myeloma
Location: East Brunswick NJ, New York NY, Lake Success NY,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT05552222
Phase 3, Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
for
Colorectal Neoplasms
Location: East Brunswick NJ, Philadelphia PA, Penn Wynne PA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06750094
Phase 3, Recruiting
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
for
Large B-cell Lymphoma
Location: East Brunswick NJ, New Brunswick NJ, Philadelphia PA,
Sponsor: Allogene Therapeutics
Sex: All
Age: 18+
Code: NCT06500273
Phase 2, Recruiting
A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small Cell Lung Cancer (Dareon®-Rosetta35)
for
Extensive-stage Small Cell Lung Carcinoma,
Location: East Brunswick NJ
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07843940
Phase 1, Phase 2, Recruiting
IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors
for
Locally Advanced Solid Tumor
Location: East Brunswick NJ, Dallas TX, Los Angeles CA
Sponsor: Fortvita Biologics (USA)Inc.
Sex: All
Age: 18+
Code: NCT06349408
Phase 1, Recruiting
Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer
for
Ovarian Cancer
Location: East Brunswick NJ, New York NY, Los Angeles CA
Sponsor: Tubulis GmbH
Sex: Female
Age: 18+
Code: NCT07736937
Phase 1, Phase 2, Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Location: East Brunswick NJ, New York NY, Baltimore MD,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07218380
Phase 3, Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
for
Prostatic Neoplasms, Castration-Resistant
Location: East Brunswick NJ, New Brunswick NJ, Camden NJ,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07225946
Phase 3, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
for
Non-Small Cell Lung Cancer, c-MET
Location: East Brunswick NJ, Lebanon NH, Brampton, Fort Wayne IN,